BioAscent will be attending and exhibiting at Discovery on Target 2022 in Boston, Massachusetts, on 17th – 20th October 2022.
Discovery on Target highlights advances in current and emerging targets, technologies, and target validation strategies for the discovery and development of novel therapeutic agents.
The event will bring together over 1,300 drug discovery professionals in Boston. Nick Moore, Director of Business Development (North America), and Christophe Auberger, Business Development Director (US) will be in attendance.
Find out more and register here.